ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS BELINOSTAT FOR THE TREATMENT OF RELAPSED OR REFRACTORY LYMPHOMA
Amengual J, Shyr Y, Durecki D, Beumer J, Mansukhani M, Williams M, Kelleher N, Cherng H, Pro B, Schwartz G, LoRusso P, Piekarz R. ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS BELINOSTAT FOR THE TREATMENT OF RELAPSED OR REFRACTORY LYMPHOMA. Hematological Oncology 2023, 41: 833-834. DOI: 10.1002/hon.3166_ot14.Peer-Reviewed Original Research